Climb­ing the block­buster moun­tain, Roche/Ab­b­Vie team her­alds a win in front­line CLL PhI­II

Ab­b­Vie $AB­BV and Roche have post­ed a goal on their piv­otal com­bi­na­tion of Ven­clex­ta and Gazy­va for front­line cas­es of chron­ic lym­pho­cyt­ic leukemia, which should …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER